Related Experiment Video
Updated: Feb 25, 2026
A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
Published on: March 7, 2017
Potential New Therapies for Pediatric Diffuse Intrinsic Pontine Glioma
Wenyong Long1, Yang Yi2,3, Shen Chen2,3
1Department of Neurosurgery, Xiangya Hospital, Central South UniversityChangsha, China.
Abstract:
Diffuse intrinsic pontine glioma (DIPG) is an extensively invasive malignancy with infiltration into other regions of the brainstem. Although large numbers of specific targeted therapies have been tested, no significant progress has been made in treating these high-grade gliomas. Therefore, the identification of new therapeutic approaches is of great importance for the development of more effective treatments. This article reviews the conventional therapies and new potential therapeutic approaches for DIPG, including epigenetic therapy, immunotherapy, and the combination of stem cells with nanoparticle delivery systems.
Insights
Diffuse intrinsic pontine glioma (DIPG) remains a challenging brainstem malignancy. This review explores novel therapeutic strategies, including epigenetic and immune-based treatments, alongside stem cell and nanoparticle combinations, to improve patient outcomes.
Area of Science:
- Neuro-oncology
- Pediatric Oncology
- Translational Medicine
Background:
- Diffuse intrinsic pontine glioma (DIPG) is a highly invasive pediatric brainstem tumor.
- Current treatments for high-grade gliomas like DIPG have shown limited efficacy.
- There is a critical need for innovative therapeutic strategies for DIPG.
Purpose of the Study:
- To review conventional therapies for DIPG.
- To explore emerging therapeutic modalities for DIPG.
- To highlight novel approaches like epigenetic therapy, immunotherapy, and stem cell-nanoparticle combinations.
Main Methods:
- Literature review of conventional and novel DIPG treatments.
- Analysis of current research in epigenetic therapy for brain tumors.
- Examination of immunotherapy approaches for pediatric gliomas.
- Review of stem cell and nanoparticle delivery systems in preclinical and clinical studies.
Main Results:
- Conventional therapies offer limited success in treating DIPG.
- Epigenetic therapies show promise in modulating tumor gene expression.
- Immunotherapy strategies are being investigated to harness the immune system against DIPG.
- Combinations of stem cells and nanoparticles offer targeted drug delivery potential.
Conclusions:
- Novel therapeutic approaches are essential for advancing DIPG treatment.
- Epigenetic therapy and immunotherapy represent promising avenues.
- Stem cell-nanoparticle systems offer innovative delivery mechanisms for DIPG therapies.
More Related Videos
07:44Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
Published on: May 2, 2025
07:39Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
Published on: November 17, 2021